Chemical Defense

The federal government's responses to chemical exposures are generally for critical incidents—military pyridostigmine bromide during Gulf War,[1][2] Agent Orange in Vietnam,[4] burn pit exposures. The VA's toxic exposure research programs are significant but reactive.[3]

Since 2006, NIAID has distributed $6B+ for chemical, biological, and radiological countermeasures. BARDA has fueled R&D for defense against hazards through Project BioShield and advance market commitments. But these programs focus on acute weaponized threats, not chronic environmental exposures.[5]

The U.S. can track a novel flu strain in real-time but cannot detect widespread chemical damage until disease manifests years later.

In 2021, the Congressionally Directed Medical Research Program created the Toxic Exposures Research Program (TERP)—funding high-risk, high-gain biomedical research on chemical exposures.

Several existing large cohorts—CHDS, Agricultural Health Study, CHAMACOS—could serve as platforms for intervention studies. Premier researchers like Prof. Pranam Chatterjee at UPenn are building in silico/in vitro infrastructure for peptide treatments against environmental pollutant binding.

Organizational models from the pandemic (Operation Warp Speed, ARPA-H) could be adapted for a coordinated chemical defense initiative:

• NIH's RADx model shows how rapid diagnostic pipelines could scale for chemical threats
• Incentivize biotech through advance market commitments and procurement guarantees
• Reconsider environmental contaminant panels in NHANES

With verified treatments for chemical exposures, there would be faster deployment of detection and response frameworks during chemical disasters (like Moss Landing or East Palestine). A National Chemical Early Warning Network could monitor population-level biomarker shifts in real-time—the chemical equivalent of wastewater surveillance for pathogens.

1. White RF, et al. Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment. Cortex. 2016. PubMed
2. Golomb BA. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci. 2008. PubMed
3. Institute of Medicine. Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines. National Academies Press. 2000. NAP
4. National Academies of Sciences. Veterans and Agent Orange: Update 11. National Academies Press. 2018. NAP
5. Trasande L, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015. PubMed